多中心25年经验中内移植物血栓形成作为血管腔内动脉瘤修复后开放转换的指征
该多中心回顾性研究分析了1997年至2022年9月意大利12个血管外科中心因主动脉内移植物血栓形成(AET)而行开放转换(OC)的16例患者,30天死亡率为12.5%(2/16),总并发症率为43.8%(7/16),1年、2年、3年估计生存率分别为80.4%、62.5%、41.7%。作者认为AET行OC通常保留用于不适合腔内治疗的复杂病例,常需肾上阻断和完全移除内移植物,似乎与高短期死亡率相关。
要点
- 因AET行OC的患者30天死亡率为12.5%(2/16),总并发症率为43.8%(7/16)。
- 16例中8例(50%)需肾上主动脉阻断,12例(75%)实现内移植物完全移除。
- 估计生存率1年为80.4%、2年为62.5%、3年为41.7%。
核心结论
- 因AET行OC通常保留用于不适合腔内治疗的复杂病例,常需肾上阻断和完全移除内移植物,似乎与高短期死亡率相关。
研究设计与样本
- 多中心回顾性分析,纳入意大利12个血管外科中心1997年至2022年9月期间EVAR后因AET行OC的病例,共16例患者,平均年龄68.6±8.5岁。
主要发现
- EVAR至OC的中位间隔时间为26.46个月(四分位距13.8-45.9)。
- 肾上主动脉阻断8/16例(50%),内移植物完全移除12/16例(75%)。
- 重建方式为主动脉双髂动脉移植8例(50%)、主动脉双股动脉旁路移植7例(43.8%)、主动脉-主动脉管状移植1例(6.3%)。
- 所有患者就诊时有症状:单侧急性肢体缺血68.7%、双侧急性肢体缺血25%、1例慢性重度跛行。
- 30天死亡率为12.5%(2/16),总并发症率为43.8%(7/16),未发现早期死亡的特异性危险因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To describe the outcomes of aortic endograft thrombosis (AET) as an indication for open conversion (OC) after endovascular aortic aneurysm repair (EVAR) in a multicenter experience. METHODS: This study retrospectively analyzed cases of OC for AET following EVAR across 12 Italian Vascular Surgery centers from 1997 to September 2022. The end points were as follows: 30-day mortality and major postoperative complications. Follow-up data included survival and aortic-related complications. RESULTS: Sixteen patients (mean age: 68.6 ± 8.5 years) were included. The median elapsed time between EVAR and OC was 26.46 months (interquartile range: 13.8-45.9). Proximal aortic cross-clamping site was supraceliac in 8 out of 16 (50%) patients, and complete removal of the stentgraft was achieved in 75% of cases (12/16 patients). Reconstructions were aorto-bi-iliac grafts in 8 cases (50%), 7 aortobifemoral bypass grafts (43.8%), and 1 aortoaortic tube graft (6.3%). All patients were symptomatic at presentation (68.7% unilateral acute limb ischemia, 25% bilateral acute limb ischemia, 1 patient had chronic severe claudication). Thirty-day mortality was 12.5% (2/16 patients). The overall morbidity rate was 43.8% (7 of 16 patients). No specific risk factors for early mortality were found. The overall estimated survival rate was 80.4% at 1 year, 62.5% at 2 years, and 41.7% at 3 years. CONCLUSIONS: OC for AET is typically reserved for complex cases that are not amenable to endovascular solutions. The frequent need for suprarenal clamping and complete endograft removal seems to be associated with high short-term mortality.
引用
- Fornasari A, Perini P, Gargiulo M, et al. Endograft Thrombosis as an Indication for Open Conversion after Endovascular Aneurysm Repair in a Multicenter Experience over 25 Years. Ann Vasc Surg. 2024. PMID: 38944191. doi:10.1016/j.avsg.2024.04.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。